Fundraising Fox
Revamedical
1 known investors
Find your way into Revamedical
Sign up to see every warm intro you have to Revamedical
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Revamedical team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
REVA Medical develops bioresorbable polymers for medical implants, with a focus on vascular applications. The company creates drug-eluting bioresorbable scaffolds for treating coronary artery disease, positioned as an alternative to permanent metallic stents.
Founders & leadership
Investors · 1
Founder mafia
3 people who came through Revamedical went on to found or lead other companies.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2004 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Revamedical do?
- REVA Medical develops bioresorbable polymers for medical implants, with a focus on vascular applications. The company creates drug-eluting bioresorbable scaffolds for treating coronary artery disease, positioned as an alternative to permanent metallic stents.
- Who are Revamedical's investors?
- Revamedical's investors include Corewell Health Ventures.